Full Kit Reta10mg GLP1,GIP,Glucagon – Reta 10mg

$240.00

- +
Guaranteed Safe Checkout

1 kit of 10 Reta 10mg vials

If not locally in stack may need to allow 2 -3 weeks for delivery

Retatrutide peptide is a synthetic, investigational triple receptor agonist being developed by Eli Lilly for the treatment of obesity, type 2 diabetes, and related metabolic conditions.  It targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, aiming to enhance weight loss, improve glycemic control, and support metabolic health.

  • Mechanism of Action: Retatrutide is a 39-amino-acid peptide engineered from a GIP backbone, featuring non-coded amino acids (Aib2, Aib20, aMeL13) and a C20 fatty diacid conjugation for stability and extended half-life (~6 days). This allows for once-weekly subcutaneous administration.

  • Clinical Efficacy: In Phase 2 and Phase 3 trials (e.g., TRIUMPH-4), retatrutide demonstrated up to 24.4% body weight reduction at 48 weeks and 71.2 lbs (32.3 kg) average weight loss at 68 weeks in adults with obesity.

  •  It also significantly reduced HbA1c, liver fat, and pain in osteoarthritis patients.

Reta 10mg! Reta is designed to help your research subjects shed pounds and achieve weight loss objectives for your research studies.

Retatrutide works by targeting specific pathways that regulate appetite and metabolism. By enhancing the test subjects natural ability to burn stored fat, this powerful formula may be exactly what you have been waiting for and certainly worth running for your studies.

This new substance is backed by extensive research and new clinical trials that are ongoing with new ones starting all the time..

Shopping Cart
Full Kit Reta 10mgFull Kit Reta10mg GLP1,GIP,Glucagon – Reta 10mg
$240.00
- +
Scroll to Top